HOME › DRUGS › BUPROPION HYDROBROMIDE
ACTIVE SUBSTANCE / INN

BUPROPION HYDROBROMIDE

Brand name(s): APLENZIN, BUPROPION HYDROBROMIDE
FDA LISTED
PRESCRIPTION
NONE (TENTATIVE APPROVAL)
NDA022108
ANDA200835
ACTIVE SUBSTANCE
Bupropion Hydrobromide
REGULATORS
FDA
SPONSORS / MAH
WATSON LABS INC, BAUSCH
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BUPROPION HYDROBROMIDEANDA200835WATSON LABS INCNone (Tentative Approval)
APLENZINNDA022108BAUSCHPrescription

FULL INTELLIGENCE ON BUPROPION HYDROBROMIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →